Lessons learned from Canadian family physicians deprescribing medications in older adults – a five-year retrospective review of medico-legal cases

Medication-related safety incidents are more common in older adults than in younger populations. Medication review and optimization, including deprescribing, are essential components of strategies to reduce medication-related harm. Deprescribing aims to minimize therapeutic burden by reducing medications that no longer provide net clinical benefit or by substituting safer alternatives. Herein we sought to use a national pan-Canadian repository of medico-legal cases to identify opportunities for improving deprescribing practices in primary care for older adults. We conducted a five-year retrospective review (2018–2022) of closed Canadian medico-legal cases relating to deprescribing involving family medicine physicians and patients age 65 or older. We analysed cases related to deprescribing and created composite case examples to illustrate both areas for improvement and examples of appropriate care despite the receipt of a complaint or civil legal action (collectively, medico-legal cases). We identified 31 medico-legal cases, of which 29 had undergone expert review. Experts identified areas of improvement related to deprescribing including conducting assessments to determine appropriateness of deprescribing, using a multidisciplinary approach to create a safe tapering plan that includes monitoring and follow-up, establishing clear communication with patients and their authorized substitute decision-makers, and documenting clearly and appropriately. Although experts often explicitly identified these elements as present, they were critical of the deprescribing-related care in half of cases. Medico-legal cases highlight several key areas for improving deprescribing in primary care, particularly around comprehensive patient assessment to inform deprescribing decision-making and clear communication of treatment plans with relevant decision-makers. The cases also demonstrate that the process of deprescribing and the patient-physician relationship is complex and that complaints can occur even when physicians are safely deprescribing.

Authors

Institutions

Publication Details

Journal
BMC Geriatrics
Published
2025-12-18
DOI
https://doi.org/10.1186/s12877-025-06894-6
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lessons learned from Canadian family physicians deprescribing medications in older adults – a five-year retrospective review of medico-legal cases

Genevieve M. Casey, Jeffrey Smith, Patricia J. Finestone, Katherine Larivière et al.
BMC Geriatrics
Pharmaceutical Practices and Patient Outcomes
article

Lessons learned from Canadian family physicians deprescribing medications in older adults – a five-year retrospective review of medico-legal cases

Genevieve M. Casey, Jeffrey Smith, Patricia J. Finestone, Katherine Larivière, Gary Garber, Cathy Zhang, Cheryl A Sadowski, Justin Lee, Catherine Bernard
article en

Abstract

Medication-related safety incidents are more common in older adults than in younger populations. Medication review and optimization, including deprescribing, are essential components of strategies to reduce medication-related harm. Deprescribing aims to minimize therapeutic burden by reducing medications that no longer provide net clinical benefit or by substituting safer alternatives. Herein we sought to use a national pan-Canadian repository of medico-legal cases to identify opportunities for improving deprescribing practices in primary care for older adults. We conducted a five-year retrospective review (2018–2022) of closed Canadian medico-legal cases relating to deprescribing involving family medicine physicians and patients age 65 or older. We analysed cases related to deprescribing and created composite case examples to illustrate both areas for improvement and examples of appropriate care despite the receipt of a complaint or civil legal action (collectively, medico-legal cases). We identified 31 medico-legal cases, of which 29 had undergone expert review. Experts identified areas of improvement related to deprescribing including conducting assessments to determine appropriateness of deprescribing, using a multidisciplinary approach to create a safe tapering plan that includes monitoring and follow-up, establishing clear communication with patients and their authorized substitute decision-makers, and documenting clearly and appropriately. Although experts often explicitly identified these elements as present, they were critical of the deprescribing-related care in half of cases. Medico-legal cases highlight several key areas for improving deprescribing in primary care, particularly around comprehensive patient assessment to inform deprescribing decision-making and clear communication of treatment plans with relevant decision-makers. The cases also demonstrate that the process of deprescribing and the patient-physician relationship is complex and that complaints can occur even when physicians are safely deprescribing.

BMC GeriatricsVol. 26(1)
University of Ottawa (CA), University of Alberta (CA), University of Toronto (CA), Canadian Medical Protective Association (CA), Ottawa Public Health (CA), Hamilton Health Sciences (CA), McMaster University (CA)
Openalex Percentile: Top 49%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.